TKNO
Alpha Teknova, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.92
−4.42%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.65x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.93x
- Price / sales
- 8.50x
- Price / cash flow
- -61.19x
Enterprise value
- Enterprise value
- $381.5M
- EV / sales
- 8.73x
- EV / EBITDA
- -40.32x
- EV / EBIT
- -24.12x
- Market cap
- $371.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026